tiprankstipranks
Trending News
More News >
RxSight (RXST)
NASDAQ:RXST
US Market

RxSight (RXST) Stock Forecast & Price Target

Compare
249 Followers
See the Price Targets and Ratings of:

RXST Analyst Ratings

Hold
8Ratings
Hold
1 Buy
6 Hold
1 Sell
Based on 8 analysts giving stock ratings to
RxSight
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RXST Stock 12 Month Forecast

Average Price Target

$11.00
▲(36.82% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for RxSight in the last 3 months. The average price target is $11.00 with a high forecast of $14.00 and a low forecast of $8.00. The average price target represents a 36.82% change from the last price of $8.04.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","13":"$13","20":"$20","27":"$27","34":"$34"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$14.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,13,20,27,34],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.83,9.227692307692308,9.625384615384615,10.023076923076923,10.420769230769231,10.818461538461538,11.216153846153846,11.613846153846154,12.01153846153846,12.409230769230769,12.806923076923077,13.204615384615384,13.602307692307692,{"y":14,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.83,8.996923076923077,9.163846153846153,9.330769230769231,9.497692307692308,9.664615384615384,9.831538461538461,9.99846153846154,10.165384615384616,10.332307692307692,10.499230769230769,10.666153846153847,10.833076923076923,{"y":11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.83,8.766153846153847,8.702307692307693,8.638461538461538,8.574615384615385,8.510769230769231,8.446923076923078,8.383076923076922,8.319230769230769,8.255384615384616,8.191538461538462,8.127692307692307,8.063846153846153,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":33.87,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.36,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.22,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.98,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.53,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.8,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.7,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 52, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":9.01,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.79,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 64, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.65,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.42,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.83,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$14.00Average Price Target$11.00Lowest Price Target$8.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on RXST
William Blair
William Blair
Hold
Initiated
01/31/26
RxSight: Unique Adjustable IOL Technology Offset by Slowing Momentum and Execution Risks Supports Hold Rating
BTIG
Hold
Reiterated
01/26/26
BTIG Sticks to Its Hold Rating for RxSight (RXST)
Piper Sandler Analyst forecast on RXST
Piper Sandler
Piper Sandler
$10$11
Hold
36.82%
Upside
Reiterated
01/20/26
RxSight price target raised to $11 from $10 at Piper SandlerRxSight price target raised to $11 from $10 at Piper Sandler
Bank of America Securities Analyst forecast on RXST
Bank of America Securities
Bank of America Securities
$8
Sell
-0.50%
Downside
Reiterated
01/12/26
Stifel Nicolaus Analyst forecast on RXST
Stifel Nicolaus
Stifel Nicolaus
$10
Hold
24.38%
Upside
Reiterated
01/12/26
Needham
$12$14
Buy
74.13%
Upside
Reiterated
01/12/26
Morgan Stanley Analyst forecast on RXST
Morgan Stanley
Morgan Stanley
$10
Hold
24.38%
Upside
Reiterated
01/12/26
RxSight new CFO will be 'well received,' says Morgan StanleyRxSight new CFO will be 'well received,' says Morgan Stanley
Wells Fargo Analyst forecast on RXST
Wells Fargo
Wells Fargo
$10$13
Hold
61.69%
Upside
Reiterated
12/12/25
Wells Fargo Reaffirms Their Hold Rating on RxSight (RXST)
J.P. Morgan Analyst forecast on RXST
J.P. Morgan
J.P. Morgan
$8$9
Sell
11.94%
Upside
Reiterated
11/06/25
RxSight price target raised to $9 from $8 at JPMorganRxSight price target raised to $9 from $8 at JPMorgan
UBS
$8
Hold
-0.50%
Downside
Reiterated
11/06/25
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), Establishment Labs Holdings (NASDAQ: ESTA) and RxSight (NASDAQ: RXST)
Jefferies Analyst forecast on RXST
Jefferies
Jefferies
$24$9
Hold
11.94%
Upside
Downgraded
07/10/25
RxSight downgraded to Hold from Buy at JefferiesRxSight downgraded to Hold from Buy at Jefferies
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on RXST
William Blair
William Blair
Hold
Initiated
01/31/26
RxSight: Unique Adjustable IOL Technology Offset by Slowing Momentum and Execution Risks Supports Hold Rating
BTIG
Hold
Reiterated
01/26/26
BTIG Sticks to Its Hold Rating for RxSight (RXST)
Piper Sandler Analyst forecast on RXST
Piper Sandler
Piper Sandler
$10$11
Hold
36.82%
Upside
Reiterated
01/20/26
RxSight price target raised to $11 from $10 at Piper SandlerRxSight price target raised to $11 from $10 at Piper Sandler
Bank of America Securities Analyst forecast on RXST
Bank of America Securities
Bank of America Securities
$8
Sell
-0.50%
Downside
Reiterated
01/12/26
Stifel Nicolaus Analyst forecast on RXST
Stifel Nicolaus
Stifel Nicolaus
$10
Hold
24.38%
Upside
Reiterated
01/12/26
Needham
$12$14
Buy
74.13%
Upside
Reiterated
01/12/26
Morgan Stanley Analyst forecast on RXST
Morgan Stanley
Morgan Stanley
$10
Hold
24.38%
Upside
Reiterated
01/12/26
RxSight new CFO will be 'well received,' says Morgan StanleyRxSight new CFO will be 'well received,' says Morgan Stanley
Wells Fargo Analyst forecast on RXST
Wells Fargo
Wells Fargo
$10$13
Hold
61.69%
Upside
Reiterated
12/12/25
Wells Fargo Reaffirms Their Hold Rating on RxSight (RXST)
J.P. Morgan Analyst forecast on RXST
J.P. Morgan
J.P. Morgan
$8$9
Sell
11.94%
Upside
Reiterated
11/06/25
RxSight price target raised to $9 from $8 at JPMorganRxSight price target raised to $9 from $8 at JPMorgan
UBS
$8
Hold
-0.50%
Downside
Reiterated
11/06/25
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), Establishment Labs Holdings (NASDAQ: ESTA) and RxSight (NASDAQ: RXST)
Jefferies Analyst forecast on RXST
Jefferies
Jefferies
$24$9
Hold
11.94%
Upside
Downgraded
07/10/25
RxSight downgraded to Hold from Buy at JefferiesRxSight downgraded to Hold from Buy at Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering RxSight

3 Months
xxx
Success Rate
14/28 ratings generated profit
50%
Average Return
+7.45%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.45% per trade.
1 Year
Success Rate
15/28 ratings generated profit
54%
Average Return
+36.15%
reiterated a buy rating last month
Copying David Saxon's trades and holding each position for 1 Year would result in 53.57% of your transactions generating a profit, with an average return of +36.15% per trade.
2 Years
xxx
Success Rate
7/18 ratings generated profit
39%
Average Return
+27.86%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 38.89% of your transactions generating a profit, with an average return of +27.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RXST Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
1
0
0
0
0
Buy
0
1
1
2
1
Hold
46
64
36
46
31
Sell
2
2
2
3
1
Strong Sell
0
0
0
0
0
total
49
67
39
51
33
In the current month, RXST has received 1 Buy Ratings, 31 Hold Ratings, and 1 Sell Ratings. RXST average Analyst price target in the past 3 months is 11.00.
Each month's total comprises the sum of three months' worth of ratings.

RXST Financial Forecast

RXST Earnings Forecast

Next quarter’s earnings estimate for RXST is -$0.34 with a range of -$0.44 to -$0.25. The previous quarter’s EPS was -$0.24. RXST beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year RXST has Performed in-line its overall industry.
Next quarter’s earnings estimate for RXST is -$0.34 with a range of -$0.44 to -$0.25. The previous quarter’s EPS was -$0.24. RXST beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year RXST has Performed in-line its overall industry.

RXST Sales Forecast

Next quarter’s sales forecast for RXST is $30.17M with a range of $26.70M to $32.61M. The previous quarter’s sales results were $30.34M. RXST beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year RXST has Performed in-line its overall industry.
Next quarter’s sales forecast for RXST is $30.17M with a range of $26.70M to $32.61M. The previous quarter’s sales results were $30.34M. RXST beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year RXST has Performed in-line its overall industry.

RXST Stock Forecast FAQ

What is RXST’s average 12-month price target, according to analysts?
Based on analyst ratings, RxSight’s 12-month average price target is 11.00.
    What is RXST’s upside potential, based on the analysts’ average price target?
    RxSight has 36.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is RXST a Buy, Sell or Hold?
          RxSight has a consensus rating of Hold which is based on 1 buy ratings, 6 hold ratings and 1 sell ratings.
            What is RxSight’s price target?
            The average price target for RxSight is 11.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $14.00 ,the lowest forecast is $8.00. The average price target represents 36.82% Increase from the current price of $8.04.
              What do analysts say about RxSight?
              RxSight’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of RXST?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.